Day One Biopharmaceuticals Inc Capital Reinvestment Ratio

Latest as of September 2024: 1.10x

Day One Biopharmaceuticals Inc capital reinvestment ratio. Day One Biopharmaceuticals Inc (DAWN) has a Capital Reinvestment Ratio of 1.10x as of September 2024, meaning it reinvests 1% of its operating cash flow ($50.75 Million) in capital expenditures ($55.72 Million). See DAWN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.10x

Capex / Operating Cash Flow

Operating Cash Flow

$50.75 Million

USD

Capital Expenditures

$55.72 Million

USD

Data as of

Sep 2024

Most recent filing

Day One Biopharmaceuticals Inc Capital Reinvestment Ratio by Year (None–None)

Day One Biopharmaceuticals Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Day One Biopharmaceuticals Inc cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow